Risk of Bacteriophage Therapeutics to Transfer Genetic Material and Contain Contaminants Beyond Endotoxins with Clinically Relevant Mitigation Strategies

Bacteriophage therapy is a promising adjuvant therapeutic in the treatment of multidrug-resistant infections and chronic biofilm infections. However, there is limited knowledge about how to best utilize these agents in vivo, leading to a wide range of treatment protocols. Moreover, while bacteriopha...

Descripción completa

Detalles Bibliográficos
Autor principal: Doub, James B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711558/
https://www.ncbi.nlm.nih.gov/pubmed/34992389
http://dx.doi.org/10.2147/IDR.S341265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711558/
https://www.ncbi.nlm.nih.gov/pubmed/34992389
http://dx.doi.org/10.2147/IDR.S341265

Ejemplares similares